Abstract
Beta2-microglobulin (β2m) determination in CSF of 72 neonates who underwent a spinal tap as part of a sepsis or meningo-encephalitis workup was performed to evaluate the usefulness of this test in the diagnosis of CNS infections. β2m was measured by enzyme immunoassay. Sixty neonates had sterile culture and normal neurological status at discharge. Twelve infants had CNS infections: 8 bacterial meningitis, 3 TORCH infections (T=toxoplasmosis, O=others, R=rubella, C=cytomegalovirus and H=herpes simplex) and 1 viral meningitis. Neonates with CNS infection exhibited significantly higher CSF β2m levels compared to neonates with sterile culture (6.24±2.66 vs 1.74±0.5 mg/l;P<0.0001). CSF β2m levels did not correlate with the white cell count, total protein concentration or glucose level in CSF. When serum and CSF levels were measured simultaneously, the CSF β2m level was significantly higher than the corresponding serum level in patients with CNS infection (6.98±2.5 vs 3.2±0.25 mg/l;P<0.01). Sensitivity, specificity, and predictive values were estimated for different cut-off points. The best operational diagnostic cut-off value was 2.25 mg/l. Receiver operating characteristic curve analysis showed an appropriate trade-off between specificity and sensitivity and indicated that CSF β2m was accurate in distinguishing between neonates with and without CNS infection.
Conclusion
CSF β2m may be a useful ancillary tool in neonates when CNS infection is suspected.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- β2m:
-
beta2-microglobulin
- ROC :
-
receiver operating characteristic
References
Alford CA, Foft JW, Blankenship WJ, Cassady G, Benton JW (1969) Subclinical central nervous system disease of neonates: a prospective study of infants born with increased levels of IgM. J Pediatr 75: 1167–1178
Alford CA, Stagno S, Reynolds DW (1974) Congenital toxoplasmosis: clinical, laboratory and therapeutic considerations, with special reference to subclinical disease. Bull N Y Acad Med 50: 160–181
Bjerrum OW, Bjerrum OJ, Borregaard N (1987) β2-microglobulin in neutrophils: an intragranular protein. J Immunol 138:3913–3917
Bonadio WA, Stanco L, Bruce R, Barry D, Smith D (1992) Reference values of normal cerebrospinal fluid composition in infants ages 0 to 8 weeks. Pediatr Infect Dis J 7: 589–591
Cresswell P, Springer T, Strominger JL, Turner MJ, Grey HM, Kubo RT (1974) Immunological identity of the small subunit of HL-A antigens and beta-2-microglobulin and its turnover on the cell membrane. Proc Natl Acad Sci USA 71: 2123–2127
Evrin P-E, Pertoft H (1973) β2-Microglobuline in human blood cells. J Immunol 111: 1147–1154
Fishman RA (1992) CSF findings in diseases of the nervous system. In: (eds) Cerebrospinal fluid in diseases of the nervous system, 2nd edn. WB Saunders, Philadelphia, pp 253–343
Gekle D, Kult J, Roth R (1977) Lysozym und β2-Mikroglobulin in liquor gesunder Kinder und bei Kindern mit Erkrankungen des Zentralnervensystems. Klin Wochenschr 55: 189–191
Grey HM, Kubo RT, Colon SM, Poulik MD, Cresswell P, Springer T, Turner M, Strominger JL (1973) The small subunit of HLA antigen is beta2-microglobuline. J Exp Med 138: 1608–1612
Hällgren R, Terent A, Venge P (1982) Lactoferrin, Lysozyme, and β2-microglobulin levels in cerebrospinal fluid. Differential indices of CNS inflammation}. Inflammation 6: 291–304
Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143: 29–36
Kaas Ibsen K (1980) β2-Microglobulin in cerebrospinal fluid from children with different diseases Acta Paediatr Scand 69: 633–635
Kin K, Kasahara T, Itoh Y, Sakurabayashi I, Kawai T, Morita M (1979) β2-microglobulin prodduction by highly purified human T and B lymphocytes in cell culture stimulated with various mitogens. Immunology 36: 47–54
Mavligit GM, Stuckey SE, Cabanillas FF, Keating MJ, Tourtellotte WW, Schold SC, Freireich EJ (1980) Diagnosis of leukemia or lymphoma in the central nervous system by beta-2-microglobulin determination. N Engl J Med 303: 718–722
Nilsson K, Evrin P-E, Welsh KI (1974) Production of β2-microglobulin by normal and malignant human cells lines and peripheral lymphocytes. Transplant Rev 21: 53–58
Peterslund NA, Black FT, Geil JP, Mogensen CE (1989) Beta-2-microglobuline in the cerebrospinal fluid of patients with infections of the central nervous system. Acta Neurol Scand 80: 579–583
Ransohoff DF, Feinstein AR (1978) Problems of spectrum in bias in evaluating the efficacy of diagnostic test. N Engl J Med 26: 926–930
Starff LD, Platt LH, McCracken GH (1976) Cerebrospinal fluid evaluation in neonates: comparison of high-risk infants with and without meningitis. J Pediatr 88: 473–477
Starmans JJP, Vos J, Van Der Helm HJ (1977) The β2-microglobuline content of the cerebrospinal fluid in neurological disease. J Neurol Sci 33: 45–49
Tennhunen R, Iivanainen M, Kovanen J (1978) Cerebrospinal fluid β2-microglobulin in neurological disorders. Acta Neurol Scand 58: 366–373
Terent A, Hällgren R, Venge P, Bergstrom (1981) Lactoferrin, lysozyme, and β2-microglobulin in cerebrospinal fluid. Elevated levels in patients with acute cerebrovascular lesions as indices of inflammation}. Stroke 12: 40–46
Volpe JJ (1987) Bacterial and fungal intracranial infections. In: Volpe JJ (eds) Neurology of the newborn. WB Saunders, Philadelphia, pp 596–635
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
García-Alix, A., Martín-Ancel, A., Ramos, M.T. et al. Cerebrospinal fluid 309-1309-1309-1in neonates with central nervous system infections. Eur J Pediatr 154, 309–313 (1995). https://doi.org/10.1007/BF01957368
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01957368